Diversifying populations of Japanese men used in study plotting their risk to prostate cancer reveals a potential dietar

July 27, 2012
Figure 1: A traditional Japanese breakfast of natto (fermented soy beans), sprinkled with compressed seaweed, is rich in vitamin K, a compound traditionally thought to fight cancer. Credit: iStockphoto/runin

Three previously unknown loci, or regions of the genome, are associated with an increased risk of Japanese men developing prostate cancer, according to RIKEN-led research on single nucleotide polymorphisms (SNPs) associated with this disease1. An SNP associated with prostate cancer at a fourth locus—related to one found earlier in European men—appears to be associated with diet, the first hard evidence of such an environmental link.

These findings are the result of a -wide association study (GWAS) by Hidewaki Nakagawa of the RIKEN Center for Genomic Medicine, Yokohama, and colleagues at universities and institutes in Japan and the USA. Repeating earlier work in Europeans, they compared the genetic profiles of Japanese groups of prostate cancer sufferers with non-sufferers. 

“We are aiming to construct a genetic risk model for the development of prostate cancer that we hope will [allow personalization of] prostate cancer diagnosis in the Japanese population,” Nakagawa says.

The researchers broadened the scope of an earlier study by adding three, more diverse, populations of Japanese men. One population included a cohort of men from Hawaii and California with Japanese ancestry. They tested nine loci that their previous study had indicated were nominally associated with the development of prostate cancer, but were not significant statistically.

The latest study not only allowed for testing of a single ethnic group likely to be affected by different environmental factors, but also provided a larger population size when combined with those surveyed in the previous work for a meta-analysis. The joint numbers included 7,141 prostate cancer sufferers and 11,804 non-sufferers.

The most recently identified loci are on chromosomes 11, 10, 3 and 2. Those on chromosomes 10 and 3 are not related to any known genes or proteins, but the researchers suggest they may be regions linked with gene regulation. The on chromosome 11 is associated with a gene whose function is unknown, but the locus on chromosome 2 is linked with GGCX, a vitamin K-dependent enzyme that regulates blood clotting, bone formation and cancer biology. Japanese foods such as natto and seaweeds are rich in vitamin K, which is thought to protect against cancer (Fig. 1). Interestingly, the association of this with was significant in all populations except for the Japanese in the USA, indicating that environmental factors, such as diet, are involved.

Explore further: Research determines apparent genetic link to prostate cancer in African-American men

More information: Akamatsu, S., et al. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nature Genetics 44, 426–429 (2012).

Related Stories

Research determines apparent genetic link to prostate cancer in African-American men

May 23, 2011
Some men of African descent may have a higher genetic risk of developing prostate cancer, according to research conducted at the Keck School of Medicine of the University of Southern California (USC).

Pinpointing asthma susceptibility in Japanese adults

December 22, 2011
A team of geneticists has identified five specific gene regions associated with asthma susceptibility among Japanese adults. Mayumi Tamari of the RIKEN Center for Genomic Medicine, Yokohama, led the research.

Recommended for you

Scientists discover possible master switch for programming cancer immunotherapy

December 11, 2017
During infection or tumor growth, a type of specialized white blood cells called CD8+ T cells rapidly multiply within the spleen and lymph nodes and acquire the ability to kill diseased cells. Some of these killer T cells ...

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

Use of chemotherapy for early stage breast cancer declines, study says

December 11, 2017
A study of nearly 3,000 women with early stage breast cancer indicates a recent, significant decline in the use of chemotherapy despite the lack of any change in national treatment recommendations or guidelines, according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.